GLP-1 Weight Loss Medications in Kentucky
Access semaglutide and tirzepatide in Kentucky through kynect Medicaid, telehealth, and local providers.
Telehealth Prescribing
AllowedRestrictions
Kentucky enacted HB 140 (2018) and expanded telehealth access during COVID. The state has permanent telehealth parity legislation. Providers must hold a Kentucky license. Audio-video and audio-only visits are permitted. Kentucky is particularly focused on telehealth for Appalachian communities.
Prescribing Rules
GLP-1 medications can be prescribed via telehealth in Kentucky without an in-person visit. Kentucky law permits non-controlled medication prescribing after establishing a patient-provider relationship through synchronous audio-video consultation. NPs and PAs have prescribing authority.
Insurance Coverage
Medicaid Coverage
Prior Authorization
Major Insurers
Kentucky was an early Medicaid expansion state (2014) under Governor Beshear, and the expansion has been one of the most successful in the nation — reducing the uninsured rate from 20% to under 5%. Kentucky Medicaid covers GLP-1s for type 2 diabetes. Weight management coverage is available through some managed care plans with prior authorization. Kentucky has one of the highest adult obesity rates at approximately 40%.
Cost Breakdown
Brand Name
$900-$1350
per month, without insurance
Compounded
Available$175-$425
per month
Top Providers in Kentucky
UK HealthCare Weight Management
In-PersonUniversity of Kentucky in Lexington offers academic obesity medicine and GLP-1 programs.
Hims & Hers
TelehealthCompounded semaglutide delivery statewide; particularly valuable for eastern Kentucky.
Norton Healthcare Weight Management
In-PersonLouisville-based health system with dedicated weight management services.
Kentucky Medicaid Expansion Success
Kentucky Medicaid expansion has been one of the most successful in the nation, reducing the uninsured rate from approximately 20% to under 5%. The program, administered through kynect (the state health exchange), covers over 500,000 adults. GLP-1 medications are covered for type 2 diabetes through Medicaid managed care organizations including Anthem, Humana, Aetna, and WellCare. Weight management coverage is more limited but is expanding as federal guidance evolves.
Appalachian Access Challenges
Eastern Kentucky Appalachian region faces some of the most severe healthcare access challenges in the country. Many counties have lost hospitals and physicians, and obesity rates in Appalachian Kentucky exceed 45% in some areas. Telehealth is essential for connecting these communities with obesity medicine specialists. Kentucky has invested in broadband expansion to support telehealth access in eastern communities, though connectivity gaps remain.
Provider Landscape
Louisville and Lexington are the primary healthcare hubs, with University of Kentucky HealthCare and Norton Healthcare offering comprehensive obesity medicine programs. Outside these cities, Bowling Green, Owensboro, and Covington (part of the Cincinnati metro) have growing provider networks. Telehealth bridges the gap for the rest of the state.
- Lexington: UK HealthCare academic obesity medicine
- Louisville: Norton Healthcare and UofL Health weight management
- Eastern Kentucky: Telehealth is the primary access pathway
Frequently Asked Questions
Kentucky Medicaid covers GLP-1s for type 2 diabetes through managed care plans. Weight management coverage is available with prior authorization under some plans. Kentucky expansion program covers over 500,000 adults.
Yes. Kentucky allows telehealth prescribing after a video consultation. This is critical for Appalachian communities with limited local healthcare. Broadband access remains a challenge in some areas but is improving.
Brand-name semaglutide costs $900-$1,350/month without insurance. Compounded semaglutide through telehealth costs $175-$425/month. Many Kentucky residents qualify for Medicaid coverage.
Kentucky has one of the highest adult obesity rates in the nation at approximately 40%. Appalachian counties in eastern Kentucky have even higher rates, driving significant demand for GLP-1 medications and weight management programs.
Explore More
Related tools, medications, and guides